Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Oct 06, 2019 4:25pm
178 Views
Post# 30201483

RE:Theralase has never traded like this before

RE:Theralase has never traded like this beforenewdaydawning wrote
I've been a shareholder for five years and I can never recall a time like last Friday's trading action, not to mention the two months prior.

So, just in the past month alone, TLT launches Ph2, discloses that P6 is still NMIBC-free, and files the FDA IND. And despite all that very positive news, the crooked market manipulators beat the SP down to a new 52-week low.

From my recollection, I've never before seen the market react this way to TLT's obvious progress and success.

Clearly the financing is in large measure responsible for this troubling pattern. But if this becomes the new norm, I think everyone here will have to ratchet down their expectations.


Maybe I've said this too many times thou I still think big pharma does have their hand in this by shorting and also accumulating shares to continue keeping the share price low they have the bucks to do this. A low share price as you know will make a stock questionable it can also afford the responsible  person or company a large percent of TLT shares which they then will have a insider position.
I really don't think that simple wallstreet article had that much of an effect to cause such a sell off ... I put my bet on big pharma knowing they might only have a few weeks left to make their move to accumulate as much as possible ... once Theralase does the presentation on Oct 25 this company will step out of the shadows.
Bullboard Posts